Folder left in public area put Indiana Health Services patients’ data at risk

Laura Pedulli | | Health Exec | Cybersecurity

About 620 Indiana Health Services (IHS) patients in South Dakota have been alerted to a breach of their personal information.

A folder accidentally left in a public area, which has since been recovered, compromised the names, Social Services numbers and Department of Veterans Affairs enrollment information of these patients, according to a release.

An investigation found that it appears no information was accessed by unauthorized information. Affected patients are receiving free credit monitoring for one year.

To prevent future incidences, all IHS staff in the great plains area will receive additional training in HIPAA privacy and security rules, according to a release.

 

Laura Pedulli

Related Content

FBI seeking extradition of Israeli prisoner accused of $500M in ransomware attacks
Data breach at chain of clinics impacts 450K patients
Nebraska becomes first state to sue Change Healthcare over data breach
Christmas ransomware exposed over 300K patient records to dark web
Cryo-frozen tissue manufacturer suffers cyberattack
First surgical device of its kind granted key FDA exemption

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.